| 000 | 02618nam a22003975i 4500 | ||
|---|---|---|---|
| 999 |
_c391125 _d391125 |
||
| 001 | 391125 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230522214201.0 | ||
| 006 | a|||| o|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 230513s2018 xxu| o |||| 0|eng d | ||
| 020 | _a9781493976744 | ||
| 024 | 7 |
_a10.1007/978-1-4939-7674-4 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aRC523 _b2018 EB |
|
| 245 | 0 | 0 |
_aBiomarkers for Preclinical Alzheimer's Disease _cedited by Robert Perneczky |
| 250 | _a1st edition 2018 | ||
| 264 | 1 |
_aNew York, NY _bSpringer International Publishing _c2018 |
|
| 300 |
_a1 recurso en línea (XIII, 272 páginas) _b39 ilustraciones, 33 ilustraciones a color |
||
| 336 |
_atexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 347 |
_aarchivo de texto _bPDF |
||
| 490 | 0 |
_aNeuromethods _x1940-6045 _v137 |
|
| 520 | _aThis volume discusses the importance of imaging, fluid, and genetic biomarkers in detecting the earliest pre-symptomatic stages of Alzheimer's disease (AD). The chapters in this book are separated into five parts. Part one explores the reasons why we need improved approaches for early detection and diagnosis of AD. Part two describes clinical and research techniques for preclinical AD diagnosis. Part three looks at the current methods in use to diagnose AD and how they can also be used for early detection in healthy older individuals. Parts four and five talk about technological advancements in AD diagnosis and ethical considerations in AD research. In Neuromethods series style, chapters include the kind of detail and key advice from the specialists needed to get successful results in your laboratory. Comprehensive and cutting-edge, Biomarkers for Preclinical Alzheimer's Disease is a valuable resource for individuals interested in the use of biomarker strategies to improve early AD detection. This book will be of great interest to researchers and clinicians from both academia and industry. | ||
| 988 | _aSpringer_Protocols_2018 | ||
| 650 | 7 |
_2embne _9144620 _aAlzheimer, Enfermedad de |
|
| 650 | 7 |
_2embne _9158907 _aNeurociencias |
|
| 776 | 0 | 8 |
_iPrinted edition: _z9781493976737 |
| 776 | 0 | 8 |
_iPrinted edition: _z9781493976751 |
| 776 | 0 | 8 |
_iPrinted edition: _z9781493992553 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-1-4939-7674-4 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b05/2023 _dz _eIG _zSI |
||